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Paclitaxel (PTX) is antiproliferative drug used for therapy of some types breast, lung 
and ovarian cancer. It stabilizes microtubules and as a result, cause inhibition of  the normal 
cell division. Unfortunately it makes no difference between normal and malignant cells and 
affect  all  proliferating  cells.  To  increase  selectivity  of  effect  of  PTX  on  cancer  cells, 
conjugates  of  PTX  with  gonadotropin-hormon  (Gn-RH)  were  prepared  in  Institute  of 
experimental botany of Czech Academy of Sciences in Prague.
The aim of our study was to compare effect of PTX conjugates and PTX alone on cell 
viability and proliferation of cell lines MDA-MB-231 and CaCo2. Cell line MDA-MB-231 is 
human breast adenocarcinoma line which express receptors for GnRH. CaCo-2 cell line is 
derived from epithelial colorectal adenocarcinoma cells which don`t express receptors for Gn-
RH. Antiproliferative effect of tested substances was monitorated by two different tests of cell 
viability and real-time cell analysis by system x-CELLigence. For appointment of cytotoxic 
effect was used primary culture of rat hepatocytes.
Obtained  results  showed  lower  antiproliferative  effect  of  derivat  MP264 
in comparation of PTX. Comparable antiproliferative effect of derivates MP265 and MP394 
with  PTX on cell  line MDA-MB-231.  Derivat  MP 264 showed lower cytotoxic  effect  in 
primary cell culture of rat hepatocytes and lower antiproliferative effect in CaCo-2 cell line. 
Stability tests proved fast degradation of MP 265 derivat in growth medium.
